Theorem Clinical Research

Global News

CISCRP Medical Heroes Appreciation 5K recognizes clinical trial volunteers

Wednesday, March 18, 2015 01:27 PM

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent, nonprofit organization based in Boston, Mass., has announced the upcoming Medical Heroes Appreciation 5K Run & Walk in Salt Lake City to celebrate the volunteers who participate in clinical research and to raise awareness about the importance of clinical research in advancing public health.

More... »

Quest Diagnostics

Patheon to acquire IRIX Pharmaceuticals

Wednesday, March 18, 2015 01:26 PM

Patheon will acquire IRIX Pharmaceuticals of Florence, S.C., which specializes in difficult to manufacture Active Pharmaceutical Ingredient (API) needs for drugs from early and late development through commercial launch. Patheon expects to close the transaction in the next 60 days.

More... »

Valeant Pharmaceuticals counterbids Endo, offers Salix $1.45B

Wednesday, March 18, 2015 01:25 PM

Valeant Pharmaceuticals International and Salix Pharmaceuticals have entered into an amendment to their Agreement and Plan of Merger, dated Feb. 20. Valeant increased the offer price to acquire all the outstanding common stock of Salix from $158 per share to $199 per share, for aggregate gross proceeds of approximately $1.45 billion.

More... »

ACRO holds initial meeting of CRO Forum

Wednesday, March 18, 2015 01:21 PM

The Association of Clinical Research Organizations (ACRO) has held the inaugural meeting of the CRO Forum in Washington, D.C. The Forum was established last October as the primary vehicle for interaction between the CRO industry and TransCelerate BioPharma.

More... »

BRANY earns five-year AAHRPP accreditation

Wednesday, March 18, 2015 01:20 PM

BRANY has successfully continued its full accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The five-year accreditation reflects BRANY’s continuing commitment to protecting the rights and welfare of research participants. AAHRPP’s accreditation process helps organizations consistently meet ethical principles and standards for protecting research participants.

More... »

Qiagen, Tokai Pharmaceuticals partner

Wednesday, March 18, 2015 01:18 PM

Qiagen, a Netherlands-based holding company, has partnered with Germany-based Tokai Pharmaceuticals to combine new circulating tumor cells (CTCs) technology with a molecular assay to co-develop and commercialize a companion diagnostic for Tokai's novel drug compound galeterone, which is in late-stage clinical trials for treatment of castration-resistant prostate cancer (CRPC). The non-invasive test will determine the expression of the AR-V7 biomarker, which in recent studies demonstrated potential utility to guide therapy choice in CRPC patients.

More... »

NantWorks, Sorrento collaborate on novel anti-cancer immunotherapies

Wednesday, March 18, 2015 01:16 PM

NantWorks, an umbrella organization developing of next generation diagnostics and therapeutics, and Sorrento Therapeutics, an oncology company, have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.

More... »

Kite Pharma acquires T-Cell Factory for $21M

Wednesday, March 18, 2015 01:14 PM

Kite Pharma, a Santa Monica, Calif.-based, clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT) products based on CAR and TCR gene therapy platforms for the treatment of cancer, acquired T-Cell Factory (TCF), a privately held Dutch company, which has been renamed Kite Pharma E.U.

More... »

$100M invested in new Dementia Discovery fund

Wednesday, March 18, 2015 01:11 PM

The U.K. government has announced over $100 million will be invested in a pioneering new global Dementia Discovery Fund. Major pharmaceutical companies Biogen Idec, GlaxoSmithKline, Johnson & JohnsonEli Lilly and Pfizer have all committed in principle to investing in the project, alongside Alzheimer's Research U.K. and the U.K. government.

More... »

Cloud Pharmaceuticals, University of Florida collaborate

Wednesday, March 18, 2015 01:09 PM

Cloud Pharmaceuticals, a Research Triangle Park, N.C.-based therapeutics company focused on cloud-based drug design and development, and the University of Florida’s department of medicine have announced an academic collaboration to help rapidly design and develop novel drugs to inhibit the reproduction of cancer cells.

More... »



March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs